๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The role of splenectomy in the management of advanced hodgkin's disease

โœ Scribed by Dr. I. A. Cooper; P. N. J. Ironside; J. P. Madigan; P. J. Morris; M. R. Ewing


Publisher
John Wiley and Sons
Year
1974
Tongue
English
Weight
982 KB
Volume
34
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis


Thirty-five patients suffering from Hodgkin's disease developed severe and persistent depression of one or all three of the peripheral blood elements, red blood cells, white blood cells, or platelets. This appeared quite commonly unrelated to any treatment, a n d in the absence of clinically demonstrable splenomegaly. In the majority of the patients included i n this series, evidence was obtained using standard radioisotopic procedures of increased cell destruction, of either red cells o r platelets with a significant number also demonstrating disorder of iron kinetics. After splenectomy, involvement of the spleen by Hodgkin's disease was demonstrated i n 23 patients. In 12 cases the spleen was not involved, but in 7 of these evidence of increased red cell destruction was shown by iron accummulation, o r destruction of platelets by myelin figures. Complete correction of peripheral blood parameters resulted in 28 with a subsequent median complete remission of 24 months, a n d improved tolerance to therapy. T h e incidence of postoperative infection was unremarkable. I t is concluded that improved tolerance to therapy can be achieved by splenectomy in patients with far advanced Hodgkin's disease even in the absence of splenic involvement .


๐Ÿ“œ SIMILAR VOLUMES


The management of Hodgkin's disease
โœ Henry S. Kaplan; Saul A. Rosenberg ๐Ÿ“‚ Article ๐Ÿ“… 1975 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 617 KB
The evolving role of etoposide in the ma
โœ Susan E. O';Reilly; P. Klimo; Joseph M. Connors ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 902 KB

Etoposide, a derivative of epipodophyllotoxin, is one of the most important new drugs that was introduced into the management of the malignant lymphomas during the past decade. A growing number of specific protocols include this useful agent in the management of malignant lymphoma, both at the time

Surgery in the management of Hodgkin's d
โœ James T. Grace Jr.; Arnold Mittelman ๐Ÿ“‚ Article ๐Ÿ“… 1966 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 443 KB ๐Ÿ‘ 2 views
Vinblastine in the treatment of advanced
โœ Dr. W. Davies Sohier Jr.; Rose K. L. Wong; Alan C. Aisenberg ๐Ÿ“‚ Article ๐Ÿ“… 1968 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 470 KB ๐Ÿ‘ 3 views

In 35 cases of advanced Hodgkin's disease (stage IIIB to IVB), of whom 33 were no longer responsive to the alkylating agents, vinblastine produced clinically useful remissions in 22 patients or 64%. Complete objective responses were unusual but one third of these cases experienced partial remissions